nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—Somnolence—Captopril—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Esmolol—Agitation—Mycophenolic acid—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Esmolol—Dyspepsia—Captopril—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Esmolol—Pulmonary oedema—Methotrexate—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Esmolol—Cardiac failure—Prednisone—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Esmolol—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Esmolol—Mental disorder—Lisinopril—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Esmolol—Dizziness—Pentoxifylline—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Esmolol—Decreased appetite—Captopril—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Esmolol—Erythema—Lisinopril—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Esmolol—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Esmolol—Syncope—Mycophenolic acid—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Esmolol—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Esmolol—Fatigue—Captopril—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Esmolol—Chest pain—Leflunomide—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Esmolol—Anxiety—Leflunomide—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Esmolol—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Esmolol—Constipation—Captopril—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Esmolol—Dysgeusia—Lisinopril—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Esmolol—Skin disorder—Azathioprine—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Esmolol—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Esmolol—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Esmolol—Dry mouth—Leflunomide—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Esmolol—Vomiting—Pentoxifylline—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Esmolol—Convulsion—Mycophenolic acid—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Esmolol—Headache—Pentoxifylline—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Esmolol—Thrombophlebitis—Methotrexate—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Esmolol—Feeling abnormal—Captopril—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Esmolol—Chest pain—Mycophenolic acid—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Esmolol—Anxiety—Mycophenolic acid—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Esmolol—Asthenia—Mometasone—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Esmolol—Irritability—Prednisone—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Esmolol—Hypotension—Azathioprine—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Esmolol—Cardiac arrest—Prednisone—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Esmolol—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Esmolol—Nervous system disorder—Leflunomide—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Esmolol—Pruritus—Mometasone—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Esmolol—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Esmolol—Skin disorder—Leflunomide—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Esmolol—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Esmolol—Angioedema—Lisinopril—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Esmolol—Confusional state—Mycophenolic acid—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Esmolol—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Esmolol—Body temperature increased—Captopril—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Esmolol—Oedema—Mycophenolic acid—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Esmolol—Anorexia—Leflunomide—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Esmolol—Nausea—Pentoxifylline—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Esmolol—Chills—Mycophenolate mofetil—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Esmolol—Syncope—Lisinopril—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Esmolol—Shock—Mycophenolic acid—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Esmolol—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Esmolol—Hypotension—Leflunomide—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Esmolol—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Esmolol—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Esmolol—Loss of consciousness—Lisinopril—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Esmolol—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Esmolol—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Esmolol—Anorexia—Mycophenolic acid—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Esmolol—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Esmolol—Paraesthesia—Leflunomide—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Esmolol—Chest pain—Lisinopril—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Esmolol—Anxiety—Lisinopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Esmolol—Dyspnoea—Leflunomide—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Esmolol—Hypotension—Mycophenolic acid—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Esmolol—Dyspepsia—Leflunomide—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Esmolol—Vomiting—Mometasone—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Esmolol—Dry mouth—Lisinopril—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Esmolol—Sweating increased—Prednisone—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Esmolol—Feeling abnormal—Azathioprine—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Esmolol—Asthenia—Captopril—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Esmolol—Decreased appetite—Leflunomide—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Esmolol—Confusional state—Lisinopril—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Esmolol—Headache—Mometasone—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Esmolol—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Esmolol—Fatigue—Leflunomide—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Esmolol—Oedema—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Esmolol—Pruritus—Captopril—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Esmolol—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Esmolol—Pain—Leflunomide—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Esmolol—Constipation—Leflunomide—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Esmolol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Esmolol—Somnolence—Mycophenolic acid—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Esmolol—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Esmolol—Shock—Lisinopril—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Esmolol—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Esmolol—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Esmolol—Body temperature increased—Azathioprine—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Esmolol—Skin disorder—Lisinopril—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Esmolol—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Esmolol—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Esmolol—Irritability—Methotrexate—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Esmolol—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Esmolol—Feeling abnormal—Leflunomide—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Esmolol—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Esmolol—Fatigue—Mycophenolic acid—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Esmolol—Nausea—Mometasone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Esmolol—Anorexia—Lisinopril—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Esmolol—Pain—Mycophenolic acid—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Esmolol—Constipation—Mycophenolic acid—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Esmolol—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Esmolol—Hypotension—Lisinopril—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Esmolol—Dizziness—Captopril—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Esmolol—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Esmolol—Urticaria—Leflunomide—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Esmolol—Body temperature increased—Leflunomide—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Esmolol—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Esmolol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Esmolol—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Esmolol—Myocardial infarction—Prednisone—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Esmolol—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Esmolol—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Esmolol—Paraesthesia—Lisinopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Esmolol—Vomiting—Captopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Esmolol—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Esmolol—Dyspnoea—Lisinopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Esmolol—Somnolence—Lisinopril—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Esmolol—Headache—Captopril—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Esmolol—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Esmolol—Dyspepsia—Lisinopril—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Esmolol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Esmolol—Oedema—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Esmolol—Decreased appetite—Lisinopril—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Esmolol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Esmolol—Fatigue—Lisinopril—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Esmolol—Shock—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Esmolol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Esmolol—Pain—Lisinopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Esmolol—Constipation—Lisinopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Esmolol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Esmolol—Bradycardia—Prednisone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Esmolol—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Esmolol—Nausea—Captopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Esmolol—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Esmolol—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Esmolol—Asthenia—Leflunomide—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Esmolol—Feeling abnormal—Lisinopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Esmolol—Pruritus—Leflunomide—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Esmolol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Esmolol—Dysuria—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Esmolol—Dizziness—Azathioprine—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Esmolol—Asthenia—Mycophenolic acid—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Esmolol—Urticaria—Lisinopril—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Esmolol—Body temperature increased—Lisinopril—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Esmolol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Esmolol—Pruritus—Mycophenolic acid—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Esmolol—Vomiting—Azathioprine—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Esmolol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Esmolol—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Esmolol—Drowsiness—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Esmolol—Flushing—Prednisone—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Esmolol—Headache—Azathioprine—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Esmolol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Esmolol—Dizziness—Leflunomide—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Esmolol—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Esmolol—Angiopathy—Prednisone—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Esmolol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Esmolol—Pain—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Esmolol—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Esmolol—Vomiting—Leflunomide—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Esmolol—Dizziness—Mycophenolic acid—systemic scleroderma	0.001	0.001	CcSEcCtD
Esmolol—Mental disorder—Prednisone—systemic scleroderma	0.001	0.001	CcSEcCtD
Esmolol—Nausea—Azathioprine—systemic scleroderma	0.001	0.001	CcSEcCtD
Esmolol—Headache—Leflunomide—systemic scleroderma	0.000996	0.000996	CcSEcCtD
Esmolol—Erythema—Prednisone—systemic scleroderma	0.000994	0.000994	CcSEcCtD
Esmolol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000986	0.000986	CcSEcCtD
Esmolol—Asthenia—Lisinopril—systemic scleroderma	0.00098	0.00098	CcSEcCtD
Esmolol—Pruritus—Lisinopril—systemic scleroderma	0.000967	0.000967	CcSEcCtD
Esmolol—Vomiting—Mycophenolic acid—systemic scleroderma	0.000964	0.000964	CcSEcCtD
Esmolol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000951	0.000951	CcSEcCtD
Esmolol—Headache—Mycophenolic acid—systemic scleroderma	0.00095	0.00095	CcSEcCtD
Esmolol—Pharyngitis—Methotrexate—systemic scleroderma	0.000947	0.000947	CcSEcCtD
Esmolol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000946	0.000946	CcSEcCtD
Esmolol—Nausea—Leflunomide—systemic scleroderma	0.000944	0.000944	CcSEcCtD
Esmolol—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000943	0.000943	CcSEcCtD
Esmolol—Urethral disorder—Methotrexate—systemic scleroderma	0.000936	0.000936	CcSEcCtD
Esmolol—Visual impairment—Methotrexate—systemic scleroderma	0.00092	0.00092	CcSEcCtD
Esmolol—Agitation—Prednisone—systemic scleroderma	0.000914	0.000914	CcSEcCtD
Esmolol—Angioedema—Prednisone—systemic scleroderma	0.000908	0.000908	CcSEcCtD
Esmolol—Dizziness—Lisinopril—systemic scleroderma	0.000903	0.000903	CcSEcCtD
Esmolol—Nausea—Mycophenolic acid—systemic scleroderma	0.000901	0.000901	CcSEcCtD
Esmolol—Syncope—Prednisone—systemic scleroderma	0.000892	0.000892	CcSEcCtD
Esmolol—Cardiac disorder—Methotrexate—systemic scleroderma	0.000886	0.000886	CcSEcCtD
Esmolol—Loss of consciousness—Prednisone—systemic scleroderma	0.000874	0.000874	CcSEcCtD
Esmolol—Vomiting—Lisinopril—systemic scleroderma	0.000869	0.000869	CcSEcCtD
Esmolol—Angiopathy—Methotrexate—systemic scleroderma	0.000866	0.000866	CcSEcCtD
Esmolol—Convulsion—Prednisone—systemic scleroderma	0.000861	0.000861	CcSEcCtD
Esmolol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000859	0.000859	CcSEcCtD
Esmolol—Chills—Methotrexate—systemic scleroderma	0.000856	0.000856	CcSEcCtD
Esmolol—Headache—Lisinopril—systemic scleroderma	0.000856	0.000856	CcSEcCtD
Esmolol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000847	0.000847	CcSEcCtD
Esmolol—Anxiety—Prednisone—systemic scleroderma	0.000844	0.000844	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000841	0.000841	CcSEcCtD
Esmolol—Mental disorder—Methotrexate—systemic scleroderma	0.000836	0.000836	CcSEcCtD
Esmolol—Erythema—Methotrexate—systemic scleroderma	0.000831	0.000831	CcSEcCtD
Esmolol—Dysgeusia—Methotrexate—systemic scleroderma	0.000814	0.000814	CcSEcCtD
Esmolol—Nausea—Lisinopril—systemic scleroderma	0.000812	0.000812	CcSEcCtD
Esmolol—Oedema—Prednisone—systemic scleroderma	0.000811	0.000811	CcSEcCtD
Esmolol—Shock—Prednisone—systemic scleroderma	0.000798	0.000798	CcSEcCtD
Esmolol—Nervous system disorder—Prednisone—systemic scleroderma	0.000796	0.000796	CcSEcCtD
Esmolol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000792	0.000792	CcSEcCtD
Esmolol—Skin disorder—Prednisone—systemic scleroderma	0.000788	0.000788	CcSEcCtD
Esmolol—Hyperhidrosis—Prednisone—systemic scleroderma	0.000784	0.000784	CcSEcCtD
Esmolol—Anorexia—Prednisone—systemic scleroderma	0.000773	0.000773	CcSEcCtD
Esmolol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000761	0.000761	CcSEcCtD
Esmolol—Headache—Mycophenolate mofetil—systemic scleroderma	0.00075	0.00075	CcSEcCtD
Esmolol—Paraesthesia—Prednisone—systemic scleroderma	0.000729	0.000729	CcSEcCtD
Esmolol—Convulsion—Methotrexate—systemic scleroderma	0.00072	0.00072	CcSEcCtD
Esmolol—Dyspepsia—Prednisone—systemic scleroderma	0.000714	0.000714	CcSEcCtD
Esmolol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000711	0.000711	CcSEcCtD
Esmolol—Chest pain—Methotrexate—systemic scleroderma	0.000707	0.000707	CcSEcCtD
Esmolol—Decreased appetite—Prednisone—systemic scleroderma	0.000705	0.000705	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000703	0.000703	CcSEcCtD
Esmolol—Fatigue—Prednisone—systemic scleroderma	0.0007	0.0007	CcSEcCtD
Esmolol—Constipation—Prednisone—systemic scleroderma	0.000694	0.000694	CcSEcCtD
Esmolol—Confusional state—Methotrexate—systemic scleroderma	0.000684	0.000684	CcSEcCtD
Esmolol—Feeling abnormal—Prednisone—systemic scleroderma	0.000669	0.000669	CcSEcCtD
Esmolol—Nervous system disorder—Methotrexate—systemic scleroderma	0.000665	0.000665	CcSEcCtD
Esmolol—Skin disorder—Methotrexate—systemic scleroderma	0.000659	0.000659	CcSEcCtD
Esmolol—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000656	0.000656	CcSEcCtD
Esmolol—Anorexia—Methotrexate—systemic scleroderma	0.000646	0.000646	CcSEcCtD
Esmolol—Urticaria—Prednisone—systemic scleroderma	0.000645	0.000645	CcSEcCtD
Esmolol—Body temperature increased—Prednisone—systemic scleroderma	0.000641	0.000641	CcSEcCtD
Esmolol—Hypotension—Methotrexate—systemic scleroderma	0.000634	0.000634	CcSEcCtD
Esmolol—Paraesthesia—Methotrexate—systemic scleroderma	0.000609	0.000609	CcSEcCtD
Esmolol—Dyspnoea—Methotrexate—systemic scleroderma	0.000605	0.000605	CcSEcCtD
Esmolol—Somnolence—Methotrexate—systemic scleroderma	0.000603	0.000603	CcSEcCtD
Esmolol—Dyspepsia—Methotrexate—systemic scleroderma	0.000597	0.000597	CcSEcCtD
Esmolol—Decreased appetite—Methotrexate—systemic scleroderma	0.000589	0.000589	CcSEcCtD
Esmolol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000585	0.000585	CcSEcCtD
Esmolol—Fatigue—Methotrexate—systemic scleroderma	0.000585	0.000585	CcSEcCtD
Esmolol—Asthenia—Prednisone—systemic scleroderma	0.000582	0.000582	CcSEcCtD
Esmolol—Pain—Methotrexate—systemic scleroderma	0.00058	0.00058	CcSEcCtD
Esmolol—Pruritus—Prednisone—systemic scleroderma	0.000574	0.000574	CcSEcCtD
Esmolol—Feeling abnormal—Methotrexate—systemic scleroderma	0.000559	0.000559	CcSEcCtD
Esmolol—Urticaria—Methotrexate—systemic scleroderma	0.000539	0.000539	CcSEcCtD
Esmolol—Dizziness—Prednisone—systemic scleroderma	0.000537	0.000537	CcSEcCtD
Esmolol—Body temperature increased—Methotrexate—systemic scleroderma	0.000536	0.000536	CcSEcCtD
Esmolol—Vomiting—Prednisone—systemic scleroderma	0.000516	0.000516	CcSEcCtD
Esmolol—Headache—Prednisone—systemic scleroderma	0.000508	0.000508	CcSEcCtD
Esmolol—Asthenia—Methotrexate—systemic scleroderma	0.000487	0.000487	CcSEcCtD
Esmolol—Nausea—Prednisone—systemic scleroderma	0.000482	0.000482	CcSEcCtD
Esmolol—Pruritus—Methotrexate—systemic scleroderma	0.00048	0.00048	CcSEcCtD
Esmolol—Dizziness—Methotrexate—systemic scleroderma	0.000448	0.000448	CcSEcCtD
Esmolol—Vomiting—Methotrexate—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Esmolol—Headache—Methotrexate—systemic scleroderma	0.000425	0.000425	CcSEcCtD
Esmolol—Nausea—Methotrexate—systemic scleroderma	0.000403	0.000403	CcSEcCtD
